Whilst sleep disturbance is not listed as a common side effect in the Summary of Product Characteristics (SmPC) for Wegovy, some patients report changes in their sleep patterns
We do not sell, dispense, or fulfill prescription medications
This observed effect appeared comparable to that observed in a control group of obese patients without MC4R variants, with the weight loss predominantly attributed to fat mass and minimal impact noted on lean body mass
Metabolites 11:113 McClean PL, Irwin N, Cassidy RS, Holst JJ, Gault VA, Flatt PR (2007) GIP receptor antagonism reverses obesity, insulin resistance, and associated metabolic disturbances induced in mice by prolonged consumption of high-fat diet
Applicable Procedure Codes: 31570, 31571, 31574, G0429, L8607, Q2026, Q2028